Budget Planning for 12 Months of GLP-1 Treatment
A practical month-by-month financial plan to make GLP-1 weight loss treatment affordable and sustainable.
Committing to 12 months of GLP-1 treatment is both a health decision and a financial one. Having a clear budget plan prevents financial stress from derailing your treatment and helps you take advantage of every cost-saving opportunity. Here is a comprehensive planning guide to make a year of treatment manageable.
12-Month Cost Overview
Annual Budget by Option
| Option | Monthly | Annual | After HSA Tax Savings* |
|---|---|---|---|
| Compounded semaglutide (budget) | $200 | $2,400 | $1,680 |
| Compounded semaglutide (mid) | $350 | $4,200 | $2,940 |
| Telehealth program (all-inclusive) | $399 | $4,788 | $3,352 |
| Compounded tirzepatide | $450 | $5,400 | $3,780 |
| Zepbound cash-pay (LillyDirect) | $550 | $6,600 | $4,620 |
*Assumes 30% combined tax savings through HSA. Your actual rate depends on your tax bracket.
Month-by-Month Breakdown
Months 1-4: Titration Phase
During titration, you start at a low dose and gradually increase. Some programs charge less during titration since the medication dose is lower. This is also when you may incur one-time startup costs.
- Medication: $200-500/month depending on option chosen
- Initial consultation: $0-150 (included in many programs)
- Lab work (optional): $50-200 (baseline metabolic panel)
- Supplies: Included or $15-30/month
Months 5-8: Active Weight Loss Phase
At therapeutic doses, weight loss accelerates. Costs are predictable and consistent during this phase.
- Medication: $200-500/month (consistent)
- Follow-up visits: Usually included; $30-75 if separate
- Optional lab work: $50-100 (midpoint check)
Months 9-12: Optimization and Transition
Weight loss may slow as you approach your goal. Your provider may adjust your dose (possibly lower), which could reduce costs. Begin discussing your maintenance plan.
- Medication: $200-500/month or potentially less at a reduced dose
- Follow-up visits: Quarterly check-ins
- Lab work: $50-200 (reassessment panel)
7 Strategies to Reduce Your 12-Month Cost
- Use an HSA or FSA. Save 20-35% immediately through pre-tax dollars. Annual savings: $500-2,000+.
- Start with semaglutide. At $200-400/month, it is the most affordable GLP-1. Switch to tirzepatide only if needed for better results.
- Choose all-inclusive programs. Programs that bundle medication, consultations, supplies, and shipping often cost less than purchasing each separately.
- Claim the tax deduction. If your total medical expenses exceed 7.5% of AGI, the tax savings add up.
- Ask about multi-month discounts. Some pharmacies and programs offer 10-15% discounts for 3-month or 6-month prepayment.
- Plan for dose reduction. Discuss with your provider whether a lower maintenance dose is appropriate once you reach your goal.
- Cut expenses elsewhere. Patients on GLP-1 medications typically spend 30-50% less on food due to reduced appetite and smaller portions. Track your grocery savings.
The Hidden Savings: Reduced Food Spending
One often-overlooked financial benefit of GLP-1 treatment is reduced food spending. Patients consistently report eating significantly less, ordering fewer restaurant meals, and buying fewer snacks and impulse foods. Conservative estimates suggest savings of $100-300 per month on food, which offsets 25-75% of medication costs.
Financing Options
If paying the full monthly cost upfront is challenging, consider these financing options:
- Medical credit cards: CareCredit offers 0% APR promotional periods
- Buy-now-pay-later: Affirm, Klarna, and Afterpay split costs into interest-free installments
- Program payment plans: Some telehealth providers offer in-house financing
- Prescription discount programs: GoodRx and similar platforms for brand-name options
Key Takeaways
- Budget $2,400-6,600 for 12 months of GLP-1 treatment depending on medication and option
- HSA/FSA accounts reduce effective costs by 20-35%
- Reduced food spending offsets 25-75% of medication costs
- Start with affordable compounded semaglutide and upgrade only if needed
- All-inclusive programs often provide better value than a la carte purchasing
- Plan for at least 12 months; many patients benefit from ongoing treatment
- The financial ROI of treating obesity makes GLP-1 treatment a sound investment
Disclaimer: Costs shown are estimates and may vary by provider, location, and program. This article is for informational purposes and is not financial advice.
Predictable, Transparent Pricing
Trimi Health's all-inclusive monthly pricing makes budgeting simple -- no surprises.
Get Started TodayMore on cost & affordability
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program.
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).